PET/MRI Imaging in High-Risk Sarcoma: First Findings and Solving Clinical Problems | Zendy

Markus K. Schuler | Zendy; Stephan Richter | Zendy; Bettina BeuthienBaumann | Zendy; Ivan Platzek | Zendy; Jörg Kotzerke | Zendy; Jörg van den Hoff | Zendy; Gerhard Ehninger | Zendy; Peter Reichardt | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

PET/MRI Imaging in High-Risk Sarcoma: First Findings and Solving Clinical Problems

Author(s) -

Markus K. Schuler,

Stephan Richter,

Bettina BeuthienBaumann,

Ivan Platzek,

Jörg Kotzerke,

Jörg van den Hoff,

Gerhard Ehninger,

Peter Reichardt

Publication year - 2013

Publication title -

case reports in oncological medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.173

H-Index - 7

eISSN - 2090-6714

pISSN - 2090-6706

DOI - 10.1155/2013/793927

Subject(s) - magnetic resonance imaging , positron emission tomography , sarcoma , radiology , medicine , modality (human–computer interaction) , pet imaging , clinical practice , nuclear medicine , medical physics , computer science , artificial intelligence , pathology , family medicine

Simultaneous positron emission tomography (PET) and magnetic resonance imaging (MRI) is a new whole-body hybrid PET/MR imaging technique that combines metabolic and cross-sectional diagnostic imaging. Since the use of MRI in imaging of soft-tissue sarcoma is extremely beneficial, investigation of the combined PET/MRI is of great interest. In this paper, we present three cases and first data. Combined PET/MRI technique can support the process of clinical decision-making and give answers to some meaningful questions when treating patients with STS. Therefore, the combined modality of simultaneous PET/MRI offers new pieces to the puzzle of sarcoma treatment.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research